{
    "2019-12-19": [
        [
            {
                "time": "2018-01-02",
                "original_text": "More Biotechs With Blockbuster Potential",
                "features": {
                    "keywords": [
                        "Biotechs",
                        "Blockbuster",
                        "Potential"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2018-01-03",
                "original_text": "Fresh off first sickle cell drug approval, Global Blood strikes new deals",
                "features": {
                    "keywords": [
                        "sickle cell",
                        "drug approval",
                        "Global Blood",
                        "new deals"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "AbbVie's JAK Inhibitor Rinvoq Receives Approval for RA in EU",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "JAK Inhibitor",
                        "Rinvoq",
                        "Approval",
                        "RA",
                        "EU"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "The Daily Biotech Pulse: Seattle Genetics' Bladder Cancer Drug Gets FDA Nod, Paratek Wins Contract For Antibiotic",
                "features": {
                    "keywords": [
                        "Seattle Genetics",
                        "Bladder Cancer",
                        "FDA Nod",
                        "Paratek",
                        "Antibiotic",
                        "Contract"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-06",
                "original_text": "Novartis plans to give away world's costliest therapy to some patients",
                "features": {
                    "keywords": [
                        "Novartis",
                        "costliest therapy",
                        "patients"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}